Literature DB >> 21949089

Cytotoxicity of the venom from the nematocysts of jellyfish Cyanea nozakii Kishinouye.

Li Cuiping1, Li Pengcheng, Feng Jinhua, Li Rongfeng, Yu Huahua.   

Abstract

In this article, the cytotoxicity of the venom from the nematocysts of jellyfish Cyanea nozakii Kishinouye on human hepatoma cells (Bel-7402, SMMC-7721) and human colon cancer cells (H630) was investigated first. Of the three kinds of cells, the venom had the strongest cytotoxicity on H630 cells with the 50% lethal concentration (IC(50)) of 5.1 μg/ml. However, the IC(50) on Bel-7402 and SMMC-7721 was approximate 17.9 and 24.3 μg/ml, respectively. The cytotoxicity of the venom was affected by pH, temperature and storage conditions. At the pH 4.5-8.5, the venom displayed obvious cytotoxicity and the percentage of survival was about 50%. When pre-incubated at temperatures over 60°C for as short as 10 min, the percentage of survival sharply improved from 4.6% up to 80%. The venom was stored in a more stable condition at -80°C and in lyophilized state compared to other storage conditions used in this study. Lactate dehydrogenase release assay performed on H630 cells indicated that exposure to the venom could result in damage to the cell membrane.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949089     DOI: 10.1177/0748233711410910

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  9 in total

Review 1.  Jellyfish from Fisheries By-Catches as a Sustainable Source of High-Value Compounds with Biotechnological Applications.

Authors:  Isabella D'Ambra; Louise Merquiol
Journal:  Mar Drugs       Date:  2022-04-14       Impact factor: 6.085

2.  Skin toxins in coral-associated Gobiodon species (Teleostei: Gobiidae) affect predator preference and prey survival.

Authors:  Barbara Gratzer; Eva Millesi; Manfred Walzl; Juergen Herler
Journal:  Mar Ecol (Berl)       Date:  2014-02-01       Impact factor: 1.693

3.  Evaluation of Cyanea capillata Sting Management Protocols Using Ex Vivo and In Vitro Envenomation Models.

Authors:  Thomas K Doyle; Jasmine L Headlam; Christie L Wilcox; Eoin MacLoughlin; Angel A Yanagihara
Journal:  Toxins (Basel)       Date:  2017-07-07       Impact factor: 4.546

4.  Persian Gulf Jellyfish (Cassiopea andromeda) Venom Fractions Induce Selective Injury and Cytochrome C Release in Mitochondria Obtained from Breast Adenocarcinoma Patients

Authors:  Mohammad Reza Mirshamsi; Ramesh Omranipour; Amir Vazirizadeh; Amir Fakhri; Fatemeh Zangeneh; Gholam Hussain Mohebbi; Ramin Seyedian; Jalal Pourahmad
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

5.  Nemopilema nomurai jellyfish venom exerts an anti-metastatic effect by inhibiting Smad- and NF-κB-mediated epithelial-mesenchymal transition in HepG2 cells.

Authors:  Hyunkyoung Lee; Min Jung Pyo; Seong Kyeong Bae; Yunwi Heo; Indu Choudhary; Duhyeon Hwang; Hyeryeon Yang; Je-Hein Kim; Jinho Chae; Chang Hoon Han; Changkeun Kang; Seungshic Yum; Euikyung Kim
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

6.  Lipid peroxidation is another potential mechanism besides pore-formation underlying hemolysis of tentacle extract from the jellyfish Cyanea capillata.

Authors:  Tao Wang; Xiao-Juan Wen; Xiao-Bin Mei; Qian-Qian Wang; Qian He; Jie-Min Zheng; Jie Zhao; Liang Xiao; Li-Ming Zhang
Journal:  Mar Drugs       Date:  2013-01-09       Impact factor: 5.118

Review 7.  Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications.

Authors:  Gian Luigi Mariottini; Luigi Pane
Journal:  Toxins (Basel)       Date:  2013-12-27       Impact factor: 4.546

Review 8.  Heated Debates: Hot-Water Immersion or Ice Packs as First Aid for Cnidarian Envenomations?

Authors:  Christie L Wilcox; Angel A Yanagihara
Journal:  Toxins (Basel)       Date:  2016-04-01       Impact factor: 4.546

Review 9.  Biotechnological Applications of Scyphomedusae.

Authors:  Louise Merquiol; Giovanna Romano; Adrianna Ianora; Isabella D'Ambra
Journal:  Mar Drugs       Date:  2019-10-24       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.